In many animal cancer models, pharmacologic activators of AMPK, such as metformin, phenformin, AICAR, and A769662, prevented or delayed the onset of tumorigenesis (Hawley et al., 2012; Yang et al., 2012; Saber et al., 2020b). The gene discussed is PRKAA1; the disease is cancer.